Trial intelligence / Profile preview

Feasibility study of L-citrulline in hypertensive pregnant women

2015-005792-25Phase 2Completed

Sponsor
Manchester University NHS Foundation Trust
Start
Jun 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of citrulline in essential hypertension and pregnancy-induced hypertension (PIH), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Feasibility and process measures. Started Jun 2018; status: completed.

02

Drugs

citrulline
03

Conditions

essential hypertensionpregnancy-induced hypertension (PIH)

Beyond the preview

Go deeper on 2015-005792-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005792-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call